The average P/S ratio for ABT's competitors is 7.08, providing a benchmark for relative valuation. Abbott Laboratories Corp (ABT) exhibits a P/S ratio of 5.01, which is -29.28% above the industry average. Given its robust revenue growth of 3.95%, this premium appears unsustainable.